The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc. and Reckitt Benckiser Group PLC., alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone.
The Justice Department in filings last week in federal court in Abingdon, Virginia, said it was intervening in four separate whistleblower lawsuits related to the Britain-based companies’ marketing of Suboxone and the related drug Subutex.
